LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 24.81 | 84.90 | 949 | 1769 | 0.5363 | 0.7349 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.51 | 84.90 | 46 | 1923 | 0.0239 | -0.1273 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.51 | 84.90 | 993 | 1923 | 0.5163 | 0.7269 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.51 | 84.90 | 24 | 1923 | 0.0125 | -0.2447 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 26.51 | 84.90 | 946 | 1923 | 0.4919 | 0.7084 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 28.21 | 84.90 | 52 | 2091 | 0.0249 | -0.1006 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 28.21 | 84.90 | 1001 | 2091 | 0.4786 | 0.7053 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 28.21 | 84.90 | 28 | 2091 | 0.0134 | -0.2133 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 28.21 | 84.90 | 942 | 2091 | 0.4504 | 0.6830 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.92 | 84.90 | 65 | 2237 | 0.0290 | -0.0550 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.92 | 84.90 | 1018 | 2237 | 0.4549 | 0.6926 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.92 | 84.90 | 32 | 2237 | 0.0143 | -0.1867 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 29.92 | 84.90 | 975 | 2237 | 0.4357 | 0.6772 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.62 | 84.90 | 53 | 2449 | 0.0216 | -0.0926 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.62 | 84.90 | 1025 | 2449 | 0.4184 | 0.6712 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.62 | 84.90 | 29 | 2449 | 0.0118 | -0.1986 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 31.62 | 84.90 | 980 | 2449 | 0.4001 | 0.6558 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.32 | 84.90 | 63 | 2722 | 0.0231 | -0.0579 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.32 | 84.90 | 1078 | 2722 | 0.3960 | 0.6619 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.32 | 84.90 | 32 | 2722 | 0.0118 | -0.1772 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 33.32 | 84.90 | 998 | 2722 | 0.3666 | 0.6365 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 35.03 | 84.90 | 83 | 2991 | 0.0277 | -0.0044 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 35.03 | 84.90 | 1093 | 2991 | 0.3654 | 0.6442 | MN20160318_Q02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 35.03 | 84.90 | 28 | 2991 | 0.0094 | -0.1941 | MN20160318_Q02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 35.03 | 84.90 | 1034 | 2991 | 0.3457 | 0.6265 | MN20160318_Q02 | E18 |